Our Founders

The Remap Story

Pricing and market access has fascinated us, ever since we initially met and cut our market access teeth whilst working for Cambridge Pharma/IMS, one of the first specialist market access consultancy in the mid noughties.

+ Read more

Market access was emerging into the mainstream of Pharma and it was obvious to us that successful navigation was going to be pivotal to companies and patients alike in the future. This was an area that was only going to get more complex as the years go by past.

After a number of years, we both ended up changing jobs, moving to Switzerland and working for separate pharma companies in Switzerland within their global and European market access teams.

During this time we commissioned multiple external market access agencies to support us in both pricing and market access strategy and implementation initiatives. This gave us a real flavour as to both the ‘good’ and ‘not so good’ consultancy approaches.

“The good”

The good being the ones that really understood the issue we were trying to address, had in-depth technical expertise, who could develop an approach that matched our budgets; who appreciated that business priorities / clinical development plans adapt and could modify their approach accordingly without additional bureaucracy!

“The bad”

The bad being those companies who did not provide sufficient senior input into projects, had exorbitant budgets, ended up telling us things we already knew or just regurgitating payer feedback without thinking of the strategy or implications for us as a pharmaceutical company.

Whilst we both enjoyed our time working within pharma, a combination of changes in personal circumstances, company re-organizations and politics, led us to think differently. We were still fascinated by pricing and market access and the need was growing exponentially. We began thinking that there must be a better way to add value to companies whilst ensuring that patients secured timely access to innovative treatments.

Over a couple of BD meetings (BD = beer drinking!), the concept of Remap (REimbursement, Market Access and Pricing) was born. Right from day 1, Paul and Graham outlined the principles of Remap:

  1. We are here to address our clients pricing and market access business needs. This means we need to understand the reason they are seeking external guidance
  2. We are adaptable to our clients’ needs and we adapt our approach to provide insights that are of interest and relevance to them, without creating additional paperwork
  3. We will only engage in projects where we can add value to our clients
  4. We will continue to educate and expand our business and pricing and market access knowledge
  5. We will have fun and ensure a healthy work life balance

Since that meeting in October 2014, we have stuck by these principles and ensure they are instilled across the Remap team.

Our Ethos & Values

Innovation motivates action to take risks, encourage curiosity and new ideas, learn from mistakes, and constantly strive to exceed expectations
Unity celebrates diversity. Synergizing the collective experiences, varied skills, and unique talents of every team member
We work smartly, take care of our team and have fun and ensure the sustainability and success of our organization whilst supporting our community and the environment
We say what we mean, and we mean what we say, we stick to our commitments and communicate openly and honestly

Meet The Team

Our dedicated team of experts are here for you

Stemming from a background of life sciences, our team have extensive experience of pricing and market access and understand payer and HTA needs.

Meet the team

Join our consultancy

Careers that excite and reward you

If you’re passionate about making a positive difference in others’ lives, have an entrepreneurial spirit, and possess a keen eye for detail, we’d love to hear from you.

View Career Opportunities

Corporate Social Responsibility

We’re serious about people & the planet

Our dedicated CSR team have implemented several policies and programmes which support the wellbeing of our colleagues, the local community, and the environment.

Check out our efforts

Diversity, Equity and Inclusion

Making every voice feel heard

Diversity, Equity and Inclusion is a big part of our company culture. We believe that by fostering an environment where every individual feels valued, respected, and included, we cultivate a culture of excellence.

Learn more

We are committed to our partners


European wide healthcare consultancy group

As the UK partner for Medvance, we address the market access challenges of pharma companies in Great Britain.

Visit website


The European Confederations of Pharmaceutical Entrepreneurs

We’re proud to be an active member, presenter and regular contributor to EUCOPE.

Visit website

Regulanet, Dr Regenold

We’re a member of regulanet®, providing pricing and market access expert insights to support members of regulanet®.

Visit website

We’re proud to be affiliated with

The association represents the interests of the Swiss Biotech industry.

Visit website

The industry association for thought leadership, professional development and ethical standards for deriving insights within UK healthcare.

Visit website

The leading professional society for health economics and outcomes research (HEOR) globally.

Visit website

I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.

Director of Market Access
Small pharma payer insights for clinical trials

Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.

Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.